Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation.
about
Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technologyIntra-Arterial Platelet Infusion for Intractable Hemorrhage and Refractory Thrombocytopenia in Children With Gastrointestinal Graft-Versus-Host Disease.Oral chronic graft-versus-host disease: analysis of dendritic cells subpopulations.Less graft-versus-host disease after rabbit antithymocyte globulin conditioning in unrelated bone marrow transplantation for leukemia and myelodysplasia: comparison with matched related bone marrow transplantationGraft-versus-host disease prophylaxis after transplantation: a network meta-analysis.Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future.Next generation treatment of acute graft-versus-host disease.[Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias].The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis.In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review.Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells.The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors.Oral cyclosporine A treatment is feasible after myeloablative conditioning in allogeneic hematopoietic stem cell transplantation.Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-γ.Acute graft-versus-host disease of the gut: considerations for the gastroenterologist.Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.Pharmacodynamics of T cell function for monitoring pharmacologic immunosuppression after allogeneic hematopoietic stem cell transplantation.Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease
P2860
Q26787225-6B1D0576-9B26-4D1E-BEC3-E0A2D7FEE5C3Q33424458-B554D550-2E4E-4E98-9E73-5D8581A487DAQ34104849-9C8A3FE6-E95A-47C9-9047-42FD37C77045Q34134601-4B03747B-B1CF-47A2-9C00-4DF8909E3475Q35499395-46F954EF-B460-4B12-B06F-C6D4E5BECF4CQ36980277-6CA701C1-F230-4227-A353-EDF79BB39913Q38221028-E7185E15-D81B-4EED-A143-E81A0E0669C5Q38382105-39ED7227-0D66-4B28-AF9D-9557A7215100Q38790014-33D67C11-86B2-4EB4-84D9-D53E8ADBCC65Q39425529-B92CDF57-98E9-4296-A69F-22066678226CQ39550464-1364E42A-FA27-4300-94F9-F9727D55DCD4Q40396484-68606FDC-7DE6-40A0-A68A-EAC63BDFE3B1Q41131559-9182C82E-0403-4778-887A-A38239340677Q49795920-E4BFB279-197B-40D8-AAF0-A7687E7C51D0Q49806345-05A6328B-972D-45C9-A521-A86BCD309FB6Q50798708-D1B0268D-CA20-41AC-A85E-DD455B2BC810Q53664646-52CD4E77-18DF-499D-95DA-6DD77178A43DQ59130037-2E2209A2-2F91-425F-A30F-554584C89214
P2860
Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prophylaxis and treatment of G ...... od and Marrow Transplantation.
@en
Prophylaxis and treatment of G ...... od and Marrow Transplantation.
@nl
type
label
Prophylaxis and treatment of G ...... od and Marrow Transplantation.
@en
Prophylaxis and treatment of G ...... od and Marrow Transplantation.
@nl
prefLabel
Prophylaxis and treatment of G ...... od and Marrow Transplantation.
@en
Prophylaxis and treatment of G ...... od and Marrow Transplantation.
@nl
P2093
P2860
P356
P1476
Prophylaxis and treatment of G ...... od and Marrow Transplantation.
@en
P2093
A Gratwohl
A Henseler
A van Biezen
B Hertenstein
D Niederwieser
L Garderet
P2860
P2888
P304
P356
10.1038/BMT.2012.45
P407
P577
2012-03-12T00:00:00Z
P5875
P6179
1049382579